Novo Nordisk, Sarepta Therapeutics & Aspire Biosciences Join Impressive Delegate List for famed Rare Diseases Conference
With the enforcement of the 1983 Orphan Drug Act (ODA), manufacturers are obliged to scale production to treat rare/orphan diseases
LONDON, UNITED KINGDOM, June 9, 2023/EINPresswire.com/ — MarketsandMarkets is pleased to announce the esteemed delegate organizations that will be participating in the highly anticipated 4th Annual Orphan Drugs and Rare Diseases Conference. The event is scheduled to take place on the 9th and 10th of October 2023 at a premier venue in London, UK.
The conference brings together industry leaders, researchers, experts, and stakeholders from the pharmaceutical, biotechnology, healthcare, and academic sectors. This platform aims to foster collaboration, share knowledge, and explore breakthrough innovations in the field of orphan drugs and rare diseases. With a focus on the latest advancements, challenges, and potential solutions, this event promises to be a milestone in the quest for improved treatments and outcomes for patients with rare conditions.
Enquire Now: https://events.marketsandmarkets.com/4th-annual-orphan-drugs-and-rare-diseases-conference-uk/enquiry
One of the key highlights of the 4th Annual Orphan Drugs and Rare Diseases Conference is the impressive lineup of renowned delegate organizations that will be in attendance. This esteemed list includes:
UCB: A global biopharmaceutical company dedicated to discovering and developing innovative medicines and solutions for people living with severe diseases.
Vertex Pharmaceuticals: A leading biotechnology company committed to transforming the lives of people with serious diseases through the discovery and development of breakthrough therapies.
Alexion Pharma: A pioneer in complement biology and a leader in rare disease innovation, focusing on transforming the lives of patients with severe and life-threatening conditions.
Novo Nordisk: A world-renowned healthcare company specializing in the development of innovative solutions for diabetes and other serious chronic diseases.
Sarepta Therapeutics: A precision genetic medicine company focused on developing transformative therapies for rare diseases characterized by RNA and protein dysregulation.
Aspire Biosciences: A cutting-edge biopharmaceutical company dedicated to developing novel therapies for orphan diseases through innovative research and strategic collaborations.
These delegate organizations, along with many other prominent industry players, will actively participate in the conference, sharing their expertise, insights, and experiences. Attendees can expect to gain significant benefits by engaging with these leaders, including networking opportunities, knowledge exchange, and potential collaborations to further advance the field of orphan drugs and rare diseases.
Become A Sponsor: https://events.marketsandmarkets.com/4th-annual-orphan-drugs-and-rare-diseases-conference-uk/become-sponsor
Key highlights of the 4th Annual Orphan Drugs and Rare Diseases Conference include:
• Thematic sessions address the latest trends, challenges, and opportunities in orphan drugs and rare diseases.
• Keynote presentations by renowned industry leaders and experts, offering valuable insights into groundbreaking research, regulatory updates, and commercial strategies.
• Panel discussions, one-on-one meetings and interactive sessions and collaboration among stakeholders from diverse backgrounds.
• Next Generation therapies treating uncommon/rare infections.
• Practices to enhance access to patient data.
• Clinical development & regulatory.
• Case studies and success stories showcasing innovative approaches, breakthrough therapies, and real-world impact.
• Dedicated sessions on emerging technologies, patient-centric approaches, and the role of digital advancements in the field.
• Digital health and Artificial intelligence.
• Existing roadblocks in orphan drug development.
• Patient Advocacy groups and their role in market access.
• Pricing and marketing plans for orphan medications.
• Revolutionary changes approaching rare diseases.
• Rare Genetic Disorders: Novel Treatment Strategies.
• Rare Neurological and oncological disorders.
• Development of multi-omics methods for RD diagnosis.
• Role of Personalized Treatment in rare diseases.
• Regenerative Medicine Approaches to Fight Complex RDs.
• Networking opportunities, including social events, cocktail receptions, and dedicated exhibition areas, facilitate valuable connections and partnerships.
Excited to become a part of this exclusive conference?
Grab the 20% off discount on registration before 30th June 2023.
USE CODE: ORD20 | REGISTER TODAY!
Conference Registration: https://events.marketsandmarkets.com/4th-annual-orphan-drugs-and-rare-diseases-conference-uk/register
Other Conferences:
6th Annual MarketsandMarkets Neuroscience R&D Conference
2nd Annual MarketsandMarkets Single Cell-Omics Conference
About MarketsandMarkets™ Conferences
MarketsandMarkets™ Conferences is a global leader in organizing B2B conferences, summits, and corporate events. Our events provide a platform for industry leaders, decision-makers, and experts to network, share knowledge, and discuss the latest developments in their respective fields. We cover a wide range of industries, including Pharma, Healthcare, Biotechnology, Information Technology, and many more. Our events are attended by excellent delegates from around the world, including Fortune 500 companies, SMEs, startups, and more.
Our conferences are focused on delivering high-quality and informative content, and we bring together leading experts from academia, industry, and government to share insights and best practices, discuss challenges and opportunities, and explore emerging trends and technologies.
At MarketsandMarkets Conferences, we are committed to providing our attendees with the most valuable and informative experience possible. We strive to create an environment that encourages collaboration, innovation, and thought leadership, and we are dedicated to delivering events that exceed our attendees’ expectations. Join us at our next conference and discover the latest trends, innovations, and best practices in your industry.
Contact US:
Nayantara Patil
MarketsandMarkets
+91 70305 60809
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Instagram
Other
